Perennial Allergic Rhinitis

• FDA label_change · 2021-02-22
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  The FDA approved a supplemental application for Singulair (montelukast sodium) filed by Organon LLC, resulting in changes to the product lab…

• FDA label_change · 2016-12-13
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Singulair (montelukast sodium) by Organon LLC, resulting in updated labeling for the product.

• FDA label_change · 2014-11-26
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  FDA approved a labeling supplemental application for Singulair (montelukast) submitted by Organon LLC.

• FDA label_change · 2011-06-10
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC, likely affecting labeling and/or indications.

• FDA label_change · 2009-01-27
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application to update the labeling for Singulair (montelukast) under Organon LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2007-04-13
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC. The approval updates the drug's labelin…